Vertex Pharmaceuticals Key Ratios (2009-2026)

Reported Financials

Vertex Pharmaceuticals Quarterly Ratios

Periods 70 quarters

Latest Jun 2026

Vertex Pharmaceuticals reported a gross margin of 85.33% and a net margin of 32.99% for the quarter ended Jun 2026. These financial ratios cover 70 quarters of results from Mar 2009 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

RatiosRatios	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026	Jun2026
Profitability
Gross Margin	88.08%	88.06%	88.28%	88.08%	87.60%	87.70%	88.76%	87.62%	87.17%	85.38%	87.27%	85.94%	85.84%	85.46%	86.90%	86.25%	86.52%	85.39%	86.85%	85.33%
EBT Margin	54.57%	42.02%	45.52%	46.64%	50.40%	46.76%	37.54%	46.59%	47.48%	45.58%	47.54%	-128.18%	44.16%	39.03%	26.37%	43.28%	42.22%	41.72%	41.95%	41.75%
EBIT Margin	53.15%	42.35%	49.63%	50.37%	48.27%	44.88%	32.80%	41.17%	41.80%	39.26%	42.35%	-132.85%	40.27%	35.23%	22.75%	38.83%	38.56%	37.80%	38.10%	37.40%
EBITDA Margin	54.75%	43.98%	51.34%	52.07%	49.84%	46.55%	34.44%	42.83%	43.50%	41.61%	44.34%	-130.81%	42.19%	36.83%	24.49%	40.57%	40.31%	39.55%	39.97%	39.10%
Operating Margin	53.15%	42.35%	49.63%	50.37%	48.27%	44.88%	32.80%	41.17%	41.80%	39.26%	42.35%	-132.85%	40.27%	35.23%	22.75%	38.83%	38.56%	37.80%	38.10%	37.40%
Net Margin	42.94%	37.16%	36.33%	36.90%	39.86%	35.56%	29.47%	36.73%	41.69%	38.48%	40.87%	-135.83%	37.71%	31.35%	23.33%	34.84%	35.20%	37.34%	34.53%	32.99%
FCF Margin	44.09%	45.03%	42.56%	49.47%	38.61%	45.37%	36.12%	43.11%	49.44%	7.01%	46.02%	-144.49%	46.97%	16.90%	28.09%	31.28%	37.04%	10.93%	43.35%	30.39%
Efficiency
Inventory AverageInventory Avg.	327.54M	343.28M	346.00M	353.30M	377.95M	424.40M	497.85M	569.30M	646.10M	713.75M	775.95M	863.85M	997.20M	1,142.60M	1,282.55M	1,429.50M	1,563.05M	1,656.80M	1,726.75M	1,765.90M
Assets AverageAssets Avg.	12,420.22M	13,025.62M	13,844.30M	14,919.15M	16,144.30M	17,428.65M	18,562.55M	19,661.70M	21,037.70M	22,228.20M	23,323.80M	22,024.75M	21,186.15M	22,386.70M	22,706.85M	23,458.60M	24,449.50M	25,252.65M	26,063.70M	26,953.85M
Equity AverageEquity Avg.	9,363.60M	9,815.40M	10,503.50M	11,420.25M	12,481.55M	13,471.15M	14,172.50M	14,951.25M	15,991.50M	17,046.60M	18,063.50M	16,660.65M	15,202.80M	16,020.25M	16,452.95M	16,835.85M	17,247.10M	17,992.30M	19,013.85M	19,804.90M
Invested CapitalInvested Cap.
Asset Utilization RatioAsset Util.	0.57	0.58	0.57	0.56	0.54	0.51	0.50	0.48	0.46	0.44	0.44	0.47	0.50	0.49	0.49	0.49	0.48	0.48	0.47	0.47
Leverage & Solvency
Interest Coverage RatioInterest Cover								91.64	95.24	93.25	109.57	-355.02	148.84	366.43	210.03	311.11	359.45	365.42
Debt Ratio
Times Interest Earned								91.64	95.24	93.25	109.57	-355.02	148.84	366.43	210.03	311.11	359.45	365.42
Valuation
Price to EarningsP/E	21.36	23.86	27.21	22.58	22.70	22.34	24.89	26.96	25.84	28.97	26.86					31.37	27.06	29.13	26.16	28.57
Price to SalesP/S	6.52	7.38	8.39	8.64	8.54	8.31	8.81	9.54	9.29	10.62	10.60	11.70	11.28	9.39	11.22	9.99	8.48	9.59	9.29	10.00
Price to BookP/B	4.88	5.53	6.12	6.05	5.70	5.33	5.62	5.86	5.43	5.96	5.82	8.19	7.67	6.31	7.55	6.64	5.74	6.17	5.86	6.22
Enterprise Value	39,512.32M	48,358.70M	58,459.30M	62,892.23M	64,538.51M	63,441.32M	70,719.50M	79,483.51M	77,729.08M	93,635.31M	97,799.12M	115,141.43M	113,345.03M	97,353.99M	118,381.91M	107,718.87M	93,170.56M	108,541.36M	106,247.67M	117,992.93M
EV to EBIT	14.91	17.38	19.92	15.42	15.55	14.73	17.48	20.04	20.05	24.44	23.33					27.45	23.33	26.01	22.70	24.70
EV to EBITDA	14.26	16.63	19.06	14.91	15.03	14.24	16.85	19.29	19.25	23.33	22.29					26.12	22.22	24.76	21.69	23.60
Market Capitalization	46,473.21M	55,883.60M	66,697.40M	72,145.63M	74,309.21M	74,219.82M	81,133.60M	90,719.81M	89,657.28M	104,853.61M	107,970.42M	120,936.93M	119,869.53M	103,469.89M	124,583.11M	114,101.67M	99,457.56M	115,149.46M	113,494.37M	125,845.33M
Price to FCFP/FCF	24.22	23.20	27.21	19.05	19.49	18.91	20.85	23.39	21.32	31.42	29.05					32.60	29.80	36.05	30.59	33.15
EV to FCF	20.59	20.08	23.85	16.61	16.92	16.16	18.18	20.49	18.48	28.06	26.31					30.78	27.92	33.99	28.64	31.08
EV to CFO	18.46	18.29	21.82	15.65	15.95	15.36	17.36	19.54	17.74	26.47	24.80					28.01	25.06	29.89	25.05	27.49
Return Ratios
Return on Sales [ROS]ROS	53.15%	42.35%	49.63%	50.37%	48.27%	44.88%	32.80%	41.17%	41.80%	39.26%	42.35%	-132.85%	40.27%	35.23%	22.75%	38.83%	38.56%	37.80%	38.10%	37.40%
Return on Capital Employed [ROCE]ROCE	25.23%	25.56%	25.16%	33.00%	30.67%	29.33%	26.04%	24.31%	22.23%	20.51%	21.47%	-1.89%	-1.57%	-1.24%	-3.92%	20.31%	19.99%	19.51%	21.10%	20.76%
Return on Invested Capital [ROIC]ROIC
Return on Assets [ROA]ROA	17.52%	17.98%	17.70%	21.41%	20.27%	19.06%	17.56%	17.11%	16.49%	16.28%	17.23%	-2.22%	-2.26%	-2.39%	-4.36%	15.51%	15.03%	15.65%	16.64%	16.34%
Return on Equity [ROE]ROE	23.24%	23.86%	23.34%	27.97%	26.22%	24.66%	23.00%	22.51%	21.70%	21.23%	22.25%	-2.94%	-3.16%	-3.34%	-6.01%	21.61%	21.31%	21.97%	22.82%	22.24%

Vertex Pharmaceuticals Ratios API

Pull Vertex Pharmaceuticals's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=VRTX&statement=Ratios&frequency=Quarter&period=all&api_key=YOUR_API_KEY

import requests

url = "https://data.businessquant.com/statements"
params = {"ticker": "VRTX", "statement": "Ratios", "frequency": "Quarter", "period": "all", "api_key": "YOUR_API_KEY"}

data = requests.get(url, params=params).json()

const res = await fetch("https://data.businessquant.com/statements?ticker=VRTX&statement=Ratios&frequency=Quarter&period=all&api_key=YOUR_API_KEY");
const data = await res.json();

API documentation

Vertex Pharmaceuticals VRTX Ratios (2009-2026)

Vertex Pharmaceuticals Quarterly Ratios

Vertex Pharmaceuticals Ratios API

Create an account

Sign In

Reset Password